MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma
Clinical trial NCT07029776 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07029776
- Sponsor
- University of Arkansas
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2030-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.